Clinical evaluations of cell-free fetal DNA quantities in pre-eclamptic pregnancies

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 3, 2013, Pages 632-640

  Zeybek, Yosun Görkem ^a   Günel, Tuba ^b   Benian, Ali ^a   Aydinli, Kilic ^a   Kaleli, Semih ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Free fetal DNA; Non invasive; Pre eclampsia; Prenatal diagnosis; Quantitative polymerase chain reaction

Indexed keywords

CELL FREE FETAL DNA; DNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; GESTATIONAL AGE; HUMAN; PREECLAMPSIA; REAL TIME POLYMERASE CHAIN REACTION; SECOND TRIMESTER ABORTION; THIRD TRIMESTER PREGNANCY; TURKEY (REPUBLIC);

ADULT; BIOLOGICAL MARKERS; DNA; FEMALE; GESTATIONAL AGE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84875247737     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.02011.x     Document Type: Article

References (24)

1. Roberts M, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357: 53-56.
2. Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
3. Lau TW, Leung TN, Chan LY et al. Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002; 48: 2141-2146.
4. Bianchi DW. Circulating fetal DNA: Its origin and diagnostic potential -a review. Placenta 2004; 18: 93-101.
5. Alberry MS, Soothhill PW. Non-invasive prenatal diagnosis: Implications for antenatal diagnosis and management of high-risk pregnancies. Semin Fetal Neonatal Med 2008; 13: 84-90.
6. Molvarec A, Szarka A, Walentin S, Szucs E, Nagy B, Rigó J Jr. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia. Hypertens Res 2010; 33: 892-898.
7. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001; 47: 137-139.
8. Zhong XY, Holzgreve W, Hahn S. The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia. Hypertens Pregnancy 2002; 21: 77-83.
9. Lo YM, Leung TN, Tein MS et al. Quantative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999; 45: 184-188.
10. Tsui DW, Chan KC, Chim SS et al. Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 2007; 27: 1212-1218.
11. Horinek A, KorabecnaM, Panczak A et al. Cell-free fetal DNA in maternal plasma during physiological single male pregnancies: Methodology issues and kinetics. Fetal Diagn Ther 2008; 24: 15-21.
12. Alberry MS, Maddocks DG, Hadi MA et al. Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and pregnancies with placental dysfunction. Am J Obstet Gynecol 2009; 200: 98.e1-98.e6.
13. Carty DM, Delles C, Dominiczak AF. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 2008; 18: 186-194.
14. Levine RJ, Qian C, LeShane ES et al. Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia. Am J Obstet Gynecol 2004; 190: 707-713.
15. Chan LY, Leung TN, Chan KC et al. Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy. Clin Chem 2003; 49: 678-680.
16. Zhong XY, Gebhardt S, Hillermann R, Tofa KC, Holzgreve W, Hahn S. Parallel assessment of circulatory fetal DNA and corticotropin-releasing hormone mRNA in early-and late-onset PET. Clin Chem 2005; 51: 1730e3.
17. Farina A, Sekizawa A, Iwasaki M, Matsuoka R, Ichizuka K, Okai T. Total cell-free DNA (b-globin gene) distribution in maternal plasma at the second trimester: A new prospective for preeclampsia screening. Prenat Diagn 2004; 24: 722-726.
18. Caramelli E, Rizzo N, Concu M et al. Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction-a pilot study. Prenat Diagn 2003; 23: 367-371.
19. Sekizawa A, Jimbo M, Saito H et al. Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003; 188: 480-484.
20. Swinkels DW, Kok JB, Hendricks JC, Wiegerinck E, Zusterzeel PL, Steegers EA. Hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome as a complication of preeclampsia in pregnant women increases the amount of cell free fetal and maternal DNA in maternal plasma and serum. Clin Chem 2002; 48: 650-653.
21. Smid M, Galbiati S, Vassallo A et al. Fetal DNA in maternal plasma in twin pregnancies. Clin Chem 2003; 49: 1526-1528.
22. Maddocks DG, Alberry M, Attilakos D et al. The SAFE project: Towards non-invasive prenatal diagnosis. Biochem Soc Trans 2009; 37: 460-465.
23. Mahoney DJ, Carey K, Fu M et al. Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise. Physiol Genomics 2004; 18: 226-231.
24. Lazar L, Rigó R Jr, Nagy B et al. Relationship of circulating cell-free DNA levels to cell-free fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet 2009; 10: 120.